Project 3: ACHIEVE- CHD

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40-75
SponsorUniversity Hospitals Cleveland Medical Center

About this trial

This project is part of the ACHIEVE GREATER (Addressing Cardiometabolic Health In Populations Through Early Prevention in the Great Lakes Region) Center (IRB 100221MP2A), the purpose of which is to reduce cardiometabolic health disparities and downstream Black-White lifespan inequality in two cities: Detroit, Michigan, and Cleveland, Ohio. The ACHIEVE GREATER Center will involve three separate but related projects that aim to mitigate health disparities in risk factor control for three chronic conditions, hypertension (HTN, Project 1), heart failure (HF, Project 2) and coronary heart disease (CHD, Project 3), which drive downstream lifespan inequality. All three projects will involve the use of Community Health Workers (CHWs) to deliver an evidence-based practice intervention program called PAL2. All three projects will also utilize the PAL2 Implementation Intervention (PAL2-II), which is a set of structured training and evaluation strategies designed to optimize CHW competence and adherence (i.e., fidelity) to the PAL2 intervention program. The present study is Project 3 of the ACHIEVE GREATER Center.

Eligibility criteria

Qualifiers

40 to 75 years of age

Self-identified as Black or African American

Residence in the Cleveland Metro Area

BMI≥30 mg/dL

Disqualifiers

Established documented cardiovascular disease (coronary artery disease, peripheral artery disease, myocardial infarction, stroke).

Systolic blood pressure ≥ 180 mmHg or diastolic blood pressure ≥ 110 mmHg

Lung disease requiring supplemental oxygen therapy

Individuals receiving treatment for cancer related disease

Trial design

Treatments tested in this trial

  • PAL2
  • CINEMA

Treatment groups

500 Participants
are divided into 2 treatment groups